Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.

O'Rourke, Matthew B; Sahni, Sumit; Samra, Jaswinder; Mittal, Anubhav; Molloy, Mark P

O'Rourke, Matthew B; Sahni, Sumit; Samra, Jaswinder; Mittal, Anubhav; Molloy, Mark P.

Afiliação

O'Rourke MB; Bowel Cancer and Biomarker Laboratory, Kolling Institute, Royal North Shore Hospital, The University of Sydney, Australia.
Sahni S; Bill Walsh Translational Cancer Laboratory, Kolling Institute, Royal North Shore Hospital, The University of Sydney, Australia.
Samra J; Upper GI Surgical Unit, Royal North Shore Hospital, Sydney, Australia.
Mittal A; Upper GI Surgical Unit, Royal North Shore Hospital, Sydney, Australia.
Molloy MP; Bowel Cancer and Biomarker Laboratory, Kolling Institute, Royal North Shore Hospital, The University of Sydney, Australia. Electronic address: m.molloy@sydney.edu.au.

J Proteomics ; 231: 103998, 2021 01 16.

Article em En | MEDLINE | ID: mdl-33027703

Assuntos

Carcinoma Ductal Pancreático; Neoplasias Pancreáticas; Biomarcadores; Carcinoma Ductal Pancreático/tratamento farmacológico; Humanos; Terapia Neoadjuvante; Neoplasias Pancreáticas/tratamento farmacológico; Proteômica

Palavras-chave

Biomarker; Complement; Data-independent acquisition; Neoadjuvant chemotherapy; Pancreatic cancer; Plasma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google